TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
ErGe BioTech AB
Closing information (x1000 NOK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
1,324
|
1,479
|
1,247 |
| Financial expenses |
0
|
1
|
1 |
| Earnings before taxes |
262
|
525
|
435 |
| EBITDA |
261
|
526
|
436 |
| Total assets |
2,015
|
1,899
|
1,426 |
| Current assets |
982
|
835
|
446 |
| Current liabilities |
53
|
172
|
218 |
| Equity capital |
1,864
|
1,598
|
1,093 |
| - share capital |
50
|
52
|
48 |
| Employees (average) |
1
|
1
|
2 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
92.5%
|
84.1%
|
76.6% |
| Turnover per employee |
1,324
|
1,479
|
624 |
| Profit as a percentage of turnover |
19.8%
|
35.5%
|
34.9% |
| Return on assets (ROA) |
13.0%
|
27.7%
|
30.6% |
| Current ratio |
1852.8%
|
485.5%
|
204.6% |
| Return on equity (ROE) |
14.1%
|
32.9%
|
39.8% |
| Change turnover |
-111
|
123
|
-42 |
| Change turnover % |
-8%
|
9%
|
-3% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
0%
|
-50%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.